Your browser doesn't support javascript.
loading
Inhibitory framing in hypersexual patients with Parkinson's disease. An fMRI pilot study.
Theis, Hendrik; Probst, Catharina; Campabadal, Anna; Goerlich, Katharina S; Granert, Oliver; Wolff, Stephan; Witt, Karsten; Deuschl, Günther; van Eimeren, Thilo.
Afiliação
  • Theis H; Faculty of Medicine, Department of Nuclear Medicine, University of Cologne, Cologne, Germany.
  • Probst C; Faculty of Medicine, Department of Neurology, University of Cologne, Cologne, Germany.
  • Campabadal A; Faculty of Medicine, Department of Nuclear Medicine, University of Cologne, Cologne, Germany.
  • Goerlich KS; Faculty of Medicine, Medical Psychology Unit, Department of Medicine, University of Barcelona, Barcelona, Spain.
  • Granert O; Department of Biomedical Sciences of Cells & Systems, Section Cognitive Neuroscience, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
  • Wolff S; Faculty of Medicine, Department of Neurology, University of Kiel, Kiel, Germany.
  • Witt K; Faculty of Medicine, Department of Radiology, University of Kiel, Kiel, Germany.
  • Deuschl G; Carl von Ossietzky-University, Department of Neurology, Evangelical Hospital Oldenburg and Research Center of Neurosensory Sciences, Oldenburg, Germany.
  • van Eimeren T; Faculty of Medicine, Department of Neurology, University of Kiel, Kiel, Germany.
Exp Brain Res ; 240(7-8): 2097-2107, 2022 Aug.
Article em En | MEDLINE | ID: mdl-35763033
Hypersexuality in medicated patients with PD is caused by an increased influence of motivational drive areas and a decreased influence of inhibitory control areas due to dopaminergic medication. In this pilot study, we test a newly developed paradigm investigating the influence of dopaminergic medication on brain activation elicited by sexual pictures with and without inhibitory contextual framing. Twenty PD patients with and without hypersexuality were examined with fMRI either OFF or ON standardized dopaminergic medication. The paradigm consisted of a priming phase where either a neutral context or an inhibitory context was presented. This priming phase was either followed by a sexual or a neutral target. Sexual, compared to neutral pictures resulted in a BOLD activation of various brain regions implicated in sexual processing. Hypersexual PD patients showed increased activity compared to PD controls in these regions. There was no relevant effect of medication between the two groups. The inhibitory context elicited less activation in inhibition-related areas in hypersexual PD, but had no influence on the perception of sexual cues. The paradigm partially worked: reactivity of motivational brain areas to sexual cues was increased in hypersexual PD and inhibitory contextual framing lead to decreased activation of inhibitory control areas in PD. We could not find a medication effect and the length of the inhibitory stimulus was not optimal to suppress reactivity to sexual cues. Our data provide new insights into the mechanisms of hypersexuality and warrant a replication with a greater cohort and an optimized stimulus length in the future.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Parkinson Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Parkinson Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article